Starpharma Holdings Limited (ASX:SPL) Announce New VivaGel(R) Clinical Trial Commences

  Melbourne, Australia, Aug 13, 2008 - (ABN Newswire) - Starpharma Holdings Limited (ASX:SPL)(PINK:SPHRY) today announced the start of its next clinical trial of VivaGel(R). The study will measure the level of antiviral activity retained by VivaGel(R) after vaginal administration. Assessment will be by laboratory assay of vaginal samples collected up to 24 hours after VivaGel(R) application.  

Sydney

  [ Change ]
 
Today

Min: 12°
Max: 17°
Rain at times.
Tomorrow

Min: 13°
Max: 18°
Rain.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online